Ehsan Jabbarzadeh, PhD, MBA

CEO
Obsidio, Inc

Presentation(s):

• Obsidio Conformable Embolic: First-in-Human clinical study

  Monday, March 6, 2023
  3:36 PM – 3:45 PM

  Disclosure information not submitted.